This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Sanabria, A. Articles by Kowalski, L. P. Search for Related Content PubMed PubMed Citation Articles by Sanabria, A. Articles by Kowalski, L. P.

Comorbidity Is a Prognostic Factor in Elderly Patients with Head and Neck Cancer

¹ Department of Head and Neck Surgery and Otorhinolaringology, Hospital do Câncer AC Camargo, Fundação Antonio Prudente, São Paulo, Brazil
² Department of Surgery, School of Medicine, Pontificia Universidad Javeriana, Bogotá, Colombia

Correspondence: Address correspondence and reprint requests to: Alvaro Sanabria, MD, MSc; Departamento de Cirurgia de Cabeça e Pescoço e Otorrinolaringologia, Hospital do Câncer AC Camargo, R. Professor Antonio Prudente, 211, 01509-900, São Paulo, Brazil; E-mail: alvarosanabria{at}gmail.com

Background: The number of aged patients with head and neck cancer is increasing. Comorbidities are common in this population. It is necessary to evaluate the effect of comorbidities as measured with the ACE-27 index on recurrence and survival of elderly patients with head and neck cancer, adjusting by other prognostic factors as age, clinical stage and functional status index.

Patients: Three hundred and ten patients greater than 70 years of age with head and neck cancer in a referral cancer center were studied. Comorbidity measured with the ACE-27 index was the main independent variable. The outcomes were recurrence and survival.

Results: Comorbidities were present in 75% of patients. Five-year disease-free survival, overall survival and cancer-specific survival were 63.1, 42.8 and 55.8%, respectively. Advanced clinical stage and Karnofsky index 70 were associated with recurrence. Age >80 years, male gender, Karnofsky index 80, advanced clinical stage, and ACE value 2 were independently associated with overall survival. The ACE-27 value was not associated with cancer-specific survival. The Karnofsky performance index was associated with overall survival and mortality and acted as a confounding factor on multivariable analysis on overall and cancer-specific survival.

Conclusions: Comorbidity measured with ACE-27 was a prognostic factor for overall survival in patients older than 70 years with head and neck cancer. The Karnofsky performance index could be included in multivariable analysis of survival for older patients with head and neck cancer.

Key Words: Head and neck neoplasms • Aged • Comorbidity • Prognosis

This article has been cited by other articles:

				A. Sanabria, A. L. Carvalho, J. G. Vartanian, J. Magrin, M. K. Ikeda, and L. P. Kowalski Validation of the Washington University Head and Neck Comorbidity Index in a Cohort of Older Patients Arch Otolaryngol Head Neck Surg, June 1, 2008; 134(6): 603 - 607. [Abstract] [Full Text] [PDF]

				J. Hopkins, D. W. Cescon, D. Tse, P. Bradbury, W. Xu, C. Ma, P. Wheatley-Price, J. Waldron, D. Goldstein, F. Meyer, et al. Genetic Polymorphisms and Head and Neck Cancer Outcomes: A Review Cancer Epidemiol. Biomarkers Prev., March 1, 2008; 17(3): 490 - 499. [Abstract] [Full Text] [PDF]

				N. Choong and E. Vokes Expanding Role of the Medical Oncologist in the Management of Head and Neck Cancer CA Cancer J Clin, January 1, 2008; 58(1): 32 - 53. [Abstract] [Full Text] [PDF]